Neogen Corp's stock plummeted 6.43% in pre-market trading following the release of its fiscal third-quarter 2026 financial results, which revealed a widening net loss and declining revenue.

The company reported a net loss of $17 million for the quarter, compared to a smaller loss in the year-ago period. Revenue fell 4.4% to $211.2 million, with the Animal Safety segment experiencing a sharp 20.1% sales decline to $54.5 million due to issues with third-party suppliers.

While Neogen raised its full-year revenue outlook to $857-$860 million and maintained its adjusted EBITDA guidance of approximately $175 million, investors reacted negatively to the weaker-than-expected quarterly performance and the significant drop in Animal Safety sales.